These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 2905151
21. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders. Wiseman LR, Faulds D. Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167 [Abstract] [Full Text] [Related]
22. Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects. Chaikin P, Gillen MS, Malik M, Pentikis H, Rhodes GR, Roberts DJ. Br J Clin Pharmacol; 2005 Mar; 59(3):346-54. PubMed ID: 15752381 [Abstract] [Full Text] [Related]
23. Effects of second generation of histamine H1 antagonists, cetirizine and ebastine, on the antitussive and rewarding effects of dihydrocodeine in mice. Kamei J, Morita K, Miyata S, Onodera K. Psychopharmacology (Berl); 2003 Mar; 166(2):176-80. PubMed ID: 12536265 [Abstract] [Full Text] [Related]
24. The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects. Vincent J, Liminana R, Meredith PA, Reid JL. Br J Clin Pharmacol; 1988 Nov; 26(5):497-502. PubMed ID: 2905150 [Abstract] [Full Text] [Related]
25. A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. Hindmarch I, Shamsi Z, Stanley N, Fairweather DB. Br J Clin Pharmacol; 1999 Aug; 48(2):200-6. PubMed ID: 10417497 [Abstract] [Full Text] [Related]
26. Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval. Malik M. Br J Clin Pharmacol; 2002 Dec; 54(6):682-3. PubMed ID: 12492623 [No Abstract] [Full Text] [Related]
27. Some clinical pharmacological studies with terfenadine, a new antihistamine drug. Kulshrestha VK, Gupta PP, Turner P, Wadsworth J. Br J Clin Pharmacol; 1978 Jul; 6(1):25-9. PubMed ID: 27203 [Abstract] [Full Text] [Related]
28. Towards the optimal antihistamine: studies with ebastine. Roberts DJ. Inflamm Res; 1998 Jul; 47 Suppl 1():S36-7. PubMed ID: 9561405 [No Abstract] [Full Text] [Related]
29. Pharmacokinetic and pharmacodynamic studies of the histamine H1-receptor antagonist ebastine in dogs. Puigdemont A, Queralt M, Jansat JM, Martinez-Tobed A. J Pharm Pharmacol; 1994 Jul; 46(7):596-9. PubMed ID: 7996390 [Abstract] [Full Text] [Related]
30. A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults. Antonijoan RM, García-Gea C, Puntes M, Valle M, Esbri R, Fortea J, Barbanoj MJ. Clin Drug Investig; 2007 Jul; 27(7):453-61. PubMed ID: 17563125 [Abstract] [Full Text] [Related]
31. Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome. Wouters MM, Balemans D, Van Wanrooy S, Dooley J, Cibert-Goton V, Alpizar YA, Valdez-Morales EE, Nasser Y, Van Veldhoven PP, Vanbrabant W, Van der Merwe S, Mols R, Ghesquière B, Cirillo C, Kortekaas I, Carmeliet P, Peetermans WE, Vermeire S, Rutgeerts P, Augustijns P, Hellings PW, Belmans A, Vanner S, Bulmer DC, Talavera K, Vanden Berghe P, Liston A, Boeckxstaens GE. Gastroenterology; 2016 Apr; 150(4):875-87.e9. PubMed ID: 26752109 [Abstract] [Full Text] [Related]
32. Effects of a sedative and of a non-sedative H1-antihistamine on the event-related potential (ERP) in normal volunteers. Swire FM, Marsden CA, Barber C, Birmingham AT. Psychopharmacology (Berl); 1989 Apr; 98(3):425-9. PubMed ID: 2568660 [Abstract] [Full Text] [Related]
33. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects. Hey JA, del Prado M, Sherwood J, Kreutner W, Egan RW. Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304 [Abstract] [Full Text] [Related]
34. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet [20 mg] versus desloratadine capsule [5 mg]: a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults. Devillier P. Clin Ther; 2007 Dec; 29(12):2774-5, author reply 2775-6. PubMed ID: 18201596 [No Abstract] [Full Text] [Related]
35. Suppression of mammalian K+ channel family by ebastine. Ko CM, Ducic I, Fan J, Shuba YM, Morad M. J Pharmacol Exp Ther; 1997 Apr; 281(1):233-44. PubMed ID: 9103502 [Abstract] [Full Text] [Related]
37. Comparison of clozapine and haloperidol on some autonomic and psychomotor functions, and on serum prolactin concentration, in healthy subjects. Pretorius JL, Phillips M, Langley RW, Szabadi E, Bradshaw CM. Br J Clin Pharmacol; 2001 Sep; 52(3):322-6. PubMed ID: 11560566 [Abstract] [Full Text] [Related]
38. Antihistamine Drug Ebastine Inhibits Cancer Growth by Targeting Polycomb Group Protein EZH2. Li Q, Liu KY, Liu Q, Wang G, Jiang W, Meng Q, Yi Y, Yang Y, Wang R, Zhu S, Li C, Wu L, Zhao D, Yan L, Zhang L, Kim JS, Zu X, Kozielski AJ, Qian W, Chang JC, Patnaik A, Chen K, Cao Q. Mol Cancer Ther; 2020 Oct; 19(10):2023-2033. PubMed ID: 32855270 [Abstract] [Full Text] [Related]
40. A study comparing the inhibitory effects of single and repeated oral doses of ebastine and fexofenadine against histamine-induced skin reactivity. Barbanoj MJ, Antonijoan RM, García-Gea C, Morte A, Gich I, Gispert J, Garcia E, Esbrí R, Luria X. Int Arch Allergy Immunol; 2003 Nov; 132(3):263-7. PubMed ID: 14646388 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]